利用可扩展的非哺乳动物系统大规模研究孤独症风险基因功能
该综述指出超过100个大效应基因与孤独症谱系障碍(ASD)强关联,但从风险基因到发现共同通路与药物靶点仍是核心挑战。线虫、果蝇、斑马鱼和热带爪蟾等可扩展非哺乳动物系统因适合高通量筛选、成本较低且易于遗传操作而具关键优势。近期研究利用这些系统分析人类罕见变异功能、评估ASD相关拷贝数变异基因间相互作用并并行研究多个ASD基因,揭示ASD基因在基本学习、感觉处理、睡眠和社会行为神经回路中的保守作用及神经发生、微管生物学和线粒体功能等共同通路。
要点
- 非哺乳动物系统适合高通量筛选ASD基因功能且成本低、易遗传操作
- 这些系统揭示ASD基因在神经发生、微管生物学和线粒体功能等共同通路
- 药理抑制筛选发现雌激素类化合物可调节ASD基因相关表型
核心结论
- 非哺乳动物系统正成为与哺乳动物和人类细胞系统并列的关键工具,用于寻找ASD基因下游汇聚机制和发现精准医学治疗。
研究设计与样本
- 综述类文章,检索范围涵盖线虫、果蝇、斑马鱼和热带爪蟾等可扩展非哺乳动物系统在ASD风险基因功能研究中的应用。
主要发现
- ASD基因在基本学习、感觉处理、睡眠和社会行为的神经回路中发挥保守作用。
- ASD基因汇聚于神经发生、微管生物学和线粒体功能等共同生物学通路。
- 非哺乳动物系统的药理抑制筛选鉴定出雌激素类化合物作为ASD基因相关表型的调节剂。
- 这些系统可并行体内分析超过100个ASD基因,促进识别具有共享生物学效应的ASD基因亚组。
关键数值与推荐
- 超过100个大效应基因与ASD强关联。
- 非哺乳动物系统可并行体内分析超过100个ASD基因。
临床怎么用
- 可利用非哺乳动物系统高通量筛选ASD风险基因功能并识别共享通路与基因亚组。
- 雌激素类化合物在非哺乳动物筛选中显示调节ASD基因相关表型,提示潜在药物发现方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There are over 100 large-effect genes strongly associated with autism spectrum disorder (ASD), yet advancing from risk genes to the discovery of common biological pathways and pharmacological targets remains a central challenge. Scalable non-mammalian systems, including Caenorhabditis elegans (roundworm), Drosophila melanogaster (fruit fly), Danio rerio (zebrafish), and Xenopus tropicalis (frog), provide critical advantages for the functional analysis of ASD genes due to their amenability to high-throughput screens, relatively low cost, and ease of genetic manipulation. Recent studies have leveraged the unique strengths of these systems to address critical challenges in ASD genetics by analyzing the function of human rare variants, evaluating interactions among genes in ASD-associated copy number variants, and investigating multiple ASD genes in parallel. These studies revealed that ASD genes play conserved roles in the neural circuits underlying basic learning, sensory processing, sleep, and social behaviors. Also, they uncovered common biological pathways uniting ASD genes, including neurogenesis, microtubule biology, and mitochondrial function. Interestingly, pharmacological suppressor screens in non-mammalian systems identified estrogenic compounds as modulators of ASD gene-associated phenotypes. Furthermore, by enabling the parallel in vivo analysis of >100 ASD genes, these systems facilitate the identification of ASD gene subgroups with shared biological effects, a critical step in drug discovery. Therefore, non-mammalian systems are emerging as key players along with mammalian and human cellular systems in the search for convergent mechanisms downstream of ASD genes and the discovery of precision medicine-based treatments.
引用
- Davidson E, Khan S, Rhee C, et al. Leveraging Scalable Non-Mammalian Systems for Large-Scale Studies of Autism Risk Gene Function. Biol Psychiatry. 2026. PMID: 42744011. doi:10.1016/j.biopsych.2026.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。